PTCOG ECR Webinar Series: Advancing Heavy Ion Therapy: Insights from Asia’s Leading Researchers
🌟 Advancing Heavy Ion Therapy: Insights from Asia’s Leading Researchers
In this session, Dr. Takahiro Oike and Dr. Min Cheol Han will present on advancements in ion therapy in Japan and South Korea.
1. Takahiro Oike
Takahiro Oike, MD, PhD, is Professor at the Heavy Ion Medical Center, Gunma University, Japan, and Adjunct Professor at Universitas Indonesia. He is a board-certified radiation oncologist and translational researcher specializing in the biological optimization of radiotherapy, including genomics-based radiosensitivity prediction and LET-guided treatment planning. After earning his MD and PhD from Gunma University, he conducted research at the National Cancer Center Japan Research Institute and the U.S. National Cancer Institute (NCI), focusing on genomics, metabolomics, and DNA damage response mechanisms. He has long served as faculty for the International Training Course on Carbon-Ion Radiotherapy (ITCCIR), co-hosted by QST and Gunma University, where he has received multiple teaching honors, including the Best Faculty Award. He currently serves as Co-Chair of the PTCOG Biology Subcommittee and as a member of the Editorial Board of the International Journal of Particle Therapy.
2. Min Cheol Han
Min Cheol Han, PhD, is Clinical Assistant Professor at Yonsei University College of Medicine, Korea. He specializes in medical physics with a particular focus on Monte Carlo simulations and particle therapy. After earning his PhD in Nuclear Engineering and Medical Physics from Hanyang University in 2017, he worked as a postdoctoral research fellow at INFN in Italy and as a visiting scientist at CERN. He later completed a clinical fellowship at Yonsei University College of Medicine and has served on its faculty since 2021. Dr. Han has authored and reviewed numerous scientific articles, holds multiple patents, and has received various grants and awards, including the 2nd ISORD Award from the Korean Association for Radiation Protection. He has also contributed to the field through service on the scientific committees of JKMP and PTCOG-AO, as well as through his membership in ICRP Task Group 103.
Session moderator: Sebastian Tattenberg
Dr. Tattenberg performed his PhD research at Massachusetts General Hospital in Boston in the US and obtained his PhD from the Ludwig Maximilian University of Munich in Germany in January 2023. He subsequently held a Mitacs-funded position at the TRIUMF national particle accelerator center in Vancouver, Canada, as well as at Laurentian and NOSM University, both in Sudbury, Canada. Sebastian is now a postdoctoral fellow at the National Research Agency of France (CNRS) and at INSA Lyon in Lyon, France.
Date
- May 28 2026
Time
- 11:00 am - 12:00 am
More Info
Labels
- Webinar
Other Organizers
-
PTCOG-ECR
-
Website
ECR Subcommitte